Inspire Medical Systems, Inc.
$56.97
▲
2.52%
2026-04-21 07:32:01
www.inspiresleep.com
NYQ: INSP
Explore Inspire Medical Systems, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.64 B
Current Price
$56.97
52W High / Low
$163.35 / $48.3
Stock P/E
11.28
Book Value
$27.33
Dividend Yield
—
ROCE
6.28%
ROE
19.77%
Face Value
—
EPS
$4.89
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
1,333
Beta
0.86
Debt / Equity
4.12
Current Ratio
6.08
Quick Ratio
4.56
Forward P/E
20.75
Price / Sales
1.71
Enterprise Value
$1.27 B
EV / EBITDA
19.54
EV / Revenue
1.39
Rating
Buy
Target Price
$77.5
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Nexalin Technology, Inc. | $0.47 | — | $9.54 M | — | -223.88% | -2.22% | $2 / $0.33 | $0.2 |
| 2. | Neuronetics, Inc. | $1.58 | — | $109.46 M | — | -28.31% | -1.35% | $4.85 / $0.8 | $0.32 |
| 3. | Sight Sciences, Inc. | $4.36 | — | $220.88 M | — | -35.58% | -50.74% | $9.24 / $2.4 | $1.2 |
| 4. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
| 5. | Catheter Precision, Inc. | $0.97 | — | $2.63 M | — | -43.77% | -1.92% | $15.68 / $0.79 | $2.62 |
| 6. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
| 7. | Butterfly Network, Inc. | $5.49 | — | $1.39 B | — | -37.34% | -42.25% | $5.62 / $1.32 | $0.77 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 269.08 M | 224.5 M | 217.09 M | 201.32 M | 239.72 M |
| Operating Profit | 46.11 M | 9.64 M | -3.32 M | -1.49 M | 31.88 M |
| Net Profit | 136.09 M | 9.93 M | -3.59 M | 2.99 M | 35.22 M |
| EPS in Rs | 4.73 | 0.34 | -0.12 | 0.1 | 1.22 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 911.98 M | 802.8 M | 624.8 M | 407.86 M |
| Operating Profit | 50.95 M | 36.08 M | -40.27 M | -47.59 M |
| Net Profit | 145.42 M | 53.51 M | -21.15 M | -44.88 M |
| EPS in Rs | 5.05 | 1.86 | -0.73 | -1.56 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 907.32 M | 808.38 M | 676.81 M | 564.88 M |
| Total Liabilities | 126.16 M | 118.69 M | 104.3 M | 68.87 M |
| Equity | 781.16 M | 689.7 M | 572.51 M | 496.01 M |
| Current Assets | 583.65 M | 630.81 M | 593.74 M | 530.03 M |
| Current Liabilities | 96.06 M | 88.5 M | 78.11 M | 61.19 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 116.98 M | 130.25 M | 24.65 M | 11.57 M |
| Investing CF | 21.45 M | -113.12 M | -294.82 M | -19.6 M |
| Financing CF | -183.45 M | -52.39 M | 13.95 M | 235.08 M |
| Free CF | 78.48 M | 91.12 M | 1.02 M | 2.47 M |
| Capex | -38.5 M | -39.12 M | -23.63 M | -9.1 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 28.49% | 53.19% | — | — |
| Earnings Growth % | 352.96% | 52.87% | — | — |
| Profit Margin % | 6.67% | -3.39% | -11% | — |
| Operating Margin % | 4.49% | -6.45% | -11.67% | — |
| Gross Margin % | 84.68% | 84.54% | 83.79% | — |
| EBITDA Margin % | 8.1% | -2.73% | -9.99% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.